ea0041ep555 | Diabetes therapy | ECE2016
Ivo Catarina
, Nunes e Silva Joao
, Simoes Helder
, Lopes Luis
, Passos Dolores
, Marcelino Mafalda
, de Castro Joao Jacome
The analogues of GLP-1(aGLP1) are a new class of anti-diabetic agents, administered subcutaneously for the treatment of Diabetes Mellitus type 2 (DM2). In the Portuguese market, there are two aGLP1 currently available: Liraglutide (once-daily administration) and Exenatide (once-weekly administration). They mimic the GLP-1, produced in the small intestine, stimulated by foods at this region, increasing the production of insulin, decreasing the satiety and slowing gastric emptyi...